Creating a strong dialogue with Europe’s biotech industries, in the autumn of 2007 the project surveyed companies to learn about contemporary bioethical concerns, positions and practices.
The questionnaire was distributed to 100 of the most innovative companies working in the following areas:
- Cell and Gene Therapies
- Stem Cells
- NanoBiotech
- BioBan
- Diagnostics
Presentation of the ongoing survey – Anne Cambon-Thomsen and Emmanuelle Rial-Sebbag, INSERM
Documents associés…
> report-of-gbp-survey-inserm-u5581
Print 
PDF 
